DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.
SOPHIA,
Actual DUPIXENT patient
since 2022.
Individual results may vary.
Before Treatment
After Treatment with
dupixent at 16 weeks
Actual 12-year-old clinical trial patient treated with DUPIXENT. This patient did not meet clinical trial criteria for clear or almost clear skin at 16 weeks. Individual results may vary.
Results from a clinical trial of patients ages 12-17 years with moderate-to-severe eczema at 16 weeks:
24% on DUPIXENT vs
2% not on DUPIXENT
37% on DUPIXENT vs
5% not on DUPIXENT
42% on DUPIXENT vs 8% not on DUPIXENT
23% on DUPIXENT vs 2% not on DUPIXENT
Long-term safety results for teens continuing on DUPIXENT in the pediatric extension study through 1 year were consistent with the adult clinical trials.
Most common side
effects include:
View the possible side effects of DUPIXENT
What you should know about the patients in this study:
Great! Sign up for DUPIXENT MyWay®, our patient support program, to access program benefits and get one-on-one support every step of the way, including help with filling your first prescription.
If you're still struggling with moderate-to-severe eczema, maybe it's time to change the conversation.
Answer a few short questions about your eczema symptoms and treatment goals. We’ll turn it into a personalized guide you can use at your next visit.
Specialists like dermatologists or allergists often have more experience treating moderate-to-severe eczema and can help create a personalized care plan for you.
Feel like you’re struggling with your symptoms?
Sign up for information that can help.
